Hypogonadism Terminated Phase 4 Trials for Testosterone (DB00624)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01084369Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With HypogonadismTreatment
NCT00240981TOM: Testosterone in Older Men With SarcopeniaTreatment
NCT01092858NEBIDO in Symptomatic Late Onset Hypogonadism (SLOH)Treatment